BioCentury
ARTICLE | Company News

Abnova Corp., EMBL deal

November 22, 2004 8:00 AM UTC

EMBL and Abnova partnered for high throughput production of monoclonal antibodies. The deal combines EMBL's automated platform and monoclonal antibody production systems with Abnova's in-house capabil...